BA: Quality Woes and Debt Cloud Turnaround Hopes
Key Takeaways
- Boeing shares at $201.18 trade at a trailing PE of 81 — but Q4's $10.59 EPS was inflated by a $9.1 billion one-time gain, masking three consecutive quarters of losses.
- The FAA cleared the 777-9 for Phase 4A certification testing on March 17, a meaningful de-risking event after years of delays from the original 2020 target.
- Fresh 737 MAX wiring flaws from a machining error threaten the 500-delivery 2026 target, even as production ramps toward 47 aircraft per month.
- Debt-to-equity of 9.92 and negative interest coverage mean Boeing cannot service its $55 billion debt load from operating income alone.
- Defense demand from the U.S.-Iran conflict provides a revenue tailwind, but commercial supply chain disruption from the same conflict is a net risk to the delivery ramp.
Boeing shares hit $201.18 on March 19 — down 21% from their 52-week high and 2.3% lower on the day — as defense stocks sold off broadly despite the U.S.-Iran conflict entering its third week. The stock has given back most of its post-Q4 rally, and the question is whether anything fundamental has changed or if this is just the market repricing risk.
Two developments in the past 48 hours demand attention. The FAA cleared the 777-9 for Phase 4A certification testing on March 17, a genuine milestone after years of delays. But fresh 737 MAX wiring flaws from a machining error surfaced in the same week, undermining the "quality culture has changed" narrative. Boeing remains a company where every step forward comes with a stumble.
Valuation: 81x Earnings Built on a One-Time Mirage
Boeing trades at a trailing PE of 80.8 on EPS of $2.49 — a figure flattered by Q4's $9.1 billion one-time gain. Exclude that windfall and trailing earnings are deeply negative. The prior three quarters produced cumulative net losses of nearly $6 billion.
Forward estimates tell a more sober story. Analysts project quarterly EPS of $1.53 to $2.51 by 2028, meaning even optimistic scenarios leave Boeing at elevated multiples for years. The consensus price target of $246 implies 22% upside from $201, but that target was set when the stock was higher — downgrades are likely if Q1 2026 disappoints.
Book value per share swung from negative $10.91 in Q3 to positive $7.10 in Q4, entirely driven by the one-time item. Traditional valuation anchors — PE, price-to-book, EV/EBITDA — are all distorted by accounting noise. At $201, you're paying for a turnaround that hasn't started delivering operationally.
Balance Sheet: $55 Billion in Debt with Negative Interest Coverage
Boeing's debt-to-equity ratio of 9.92 would be alarming in any industry. Interest coverage sits at negative 1.24 — the company cannot service its debt from operating income. It relies on asset sales, capital markets access, and one-time gains to stay solvent.
The current ratio of 1.27 provides a thin liquidity buffer, but inventory days at 344 reflect massive work-in-progress tied up in undelivered aircraft. Every 737 MAX sitting on the tarmac awaiting rework is capital earning nothing.
Free cash flow per share was negative $1.54 in Q4, following positive $2.37 in Q3 — the inconsistency makes it impossible to model a reliable free cash flow trajectory. Until Boeing strings together consecutive quarters of positive FCF sufficient to service debt organically, the balance sheet remains the single biggest risk to equity holders.
777-9 Certification: A Genuine Catalyst, Finally
The FAA cleared Boeing's 777-9 for Phase 4A certification testing on March 17 — a significant de-risking event. Phase 4 involves FAA pilots and engineers directly participating in flight tests, verifying that the world's largest twin-engine jet meets all safety and performance standards.
This matters because the 777-9 program has been a $15 billion charge against Boeing's commercial division. First deliveries are now targeted for 2027, with Ryanair CEO Michael O'Leary publicly stating on March 19 that he expects MAX 10 certification in Q3 2026 with deliveries on schedule for early 2027.
The certification progress is real, but investors should remember that Boeing has missed 777X deadlines repeatedly since the original 2020 target. Phase 4A is a milestone, not the finish line. The commercial division won't reach profitability until these planes are actually delivering.
Quality Failures and the Iran Supply Chain Risk
Fresh 737 MAX wiring flaws from a machining error emerged in March, threatening delivery schedules just as Boeing logged its best February numbers since 2017 — targeting 500 deliveries for 2026 with production ramping to 47 per month by summer.
Boeing says the fix will be quick and won't impact 2026 targets, but every new quality incident reopens the question of whether the company's manufacturing culture has genuinely changed since the 737 MAX crashes. A pattern of "discover, patch, reassure" is not the same as systemic quality improvement.
Meanwhile, the U.S.-Iran conflict adds a new variable. Boeing has asked suppliers to assess production impact from a war now in its third week, which has disrupted flights, shipping, and parts transport to Middle East carriers. Defense demand is surging — a $166.8 million Navy P-8A Poseidon contract landed on March 2 — but defense margins can't offset commercial disruption at scale. The conflict is a net positive for Boeing's defense order book but a logistics headache for its commercial recovery.
Forward Outlook: Defense Tailwind, Execution Risk Everywhere Else
Boeing's bull case rests on three pillars: commercial delivery ramp, 777-9 certification, and defense demand. Two of three are trending in the right direction. Defense contracts are flowing — the $4.2 billion E-4B "Nightwatch" nuclear command aircraft award plus ongoing P-8A and F/A-18 work provide revenue visibility. Institutional buying continues, with AIA Group increasing its Boeing position by 31.4% and Danske Bank opening a new stake.
The bear case is that $201 still prices in too much execution that Boeing hasn't demonstrated. The company needs to deliver 500 planes in 2026 without major quality setbacks, advance 777-9 through remaining certification phases, and generate consistent positive free cash flow — all while managing $55 billion in debt with negative interest coverage.
At 21% below its 52-week high and with earnings expected April 22, Boeing is a show-me story. The 777-9 progress and defense demand are genuine positives, but the valuation still demands years of flawless execution. Investors with a 3-5 year horizon and tolerance for volatility may find value, but the risk-reward at $201 favours patience over conviction.
Conclusion
Boeing at $201 is cheaper than it was at $254, but "cheaper" and "cheap" are different things. A trailing PE of 81 on earnings inflated by a one-time gain, $55 billion in debt with negative interest coverage, and a manufacturing quality culture that keeps producing new defects — none of this screams value.
The 777-9 certification progress and defense order flow are real positives that didn't exist six months ago. If Boeing hits its 500-delivery target for 2026 and advances the 777-9 through remaining certification phases, the stock has meaningful upside to the $246 consensus target. That's a lot of "ifs" for a company with Boeing's recent track record.
Earnings on April 22 will be the next inflection point. Until then, the stock is a hold for existing positions and a watchlist name for everyone else. The turnaround thesis is intact but unproven — and $55 billion in debt leaves zero room for the next quality scandal.
Frequently Asked Questions
Sources & References
seekingalpha.com
www.reuters.com
www.usnews.com
www.investors.com
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.